NAD Refers IV Drips to FDA and FTC for Claims that IV Hydration Therapy Protects Against COVID-19
For Immediate Release
New York, NY – July 30, 2020 – The National Advertising Division (NAD), a division of BBB National Programs, has referred advertising claims made by IV Drips, Customized IV Hydration & Wellness (“IV Drips”) for its IV Hydration Therapy to the U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC) for review. The advertiser did not respond to NAD’s request to provide substantiation for its claims.
Through their routine monitoring program, NAD challenged IV Drip’s Instagram post for IV Hydration Therapy, including an image with the text:
“Protect Yourself & Your Loved Ones Boost Your Immune System,”
Associated text stating “Trump Declares National Emergency Over COVID-19,” and
“Stay Safe. Stay Healthy. Strengthen your first line of defense with an immunity Drip.”
NAD determined that the immunity-boosting claims, together with references to COVID-19, reasonably convey the implied message that IV Hydration Therapy protects users against COVID-19.
NAD noted that the U.S. Centers for Disease Control and Prevention (CDC) and the FDA have both stated that there are no approved vaccines, drugs, or investigational products currently available to treat or prevent COVID-19. Both the FDA and FTC have issued dozens of warning letters to companies making claims about their products’ ability to treat or prevent COVID-19. Health and safety concerns are a top priority for NAD’s monitoring efforts, with attention currently focused on advertising for COVID-19 treatments.
NAD was disappointed that the advertiser did not participate in the self-regulatory process, despite repeated outreach attempts. Considering the advertiser’s failure to provide a substantive response to NAD’s request for substantiation for its claims or participate in any way in the self-regulatory process, NAD has referred the matter to the FDA and FTC for possible enforcement action.
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
Latest Decisions
National Advertising Division Recommends Naked & Thriving Discontinue Certain Claims; Advertiser Voluntarily Modifies Bare Beauty Babes Website
New York, NY – March 26, 2024 – BBB National Programs’ National Advertising Division, as part of its routine monitoring program, recommended that Naked & Thriving discontinue certain claims in the Bare Beauty Babes blog and on social media.
National Advertising Division Refers Claims for Spectrum Home Internet Service to Regulatory Authorities for Further Review
New York, NY – March 21, 2024 – The National Advertising Division has referred advertising claims made by Charter Communications for its Spectrum home internet service to the FTC and other regulatory authorities for review after Charter declined to participate in the industry self-regulation process.
Following National Advertising Division Challenge, NourishMax Voluntarily Discontinues Certain Claims for its Diamond Infused Eye Cream
New York, NY – March 21, 2024 – Following a challenge brought by the National Advertising Division as part of its routine monitoring program, NourishMax discontinued certain advertising claims used to promote its NourishMax Diamond Infused Eye Cream.
Following National Advertising Division Challenge, Mobile Fox Voluntarily Discontinues Certain Claims for Solitaire Arena Game
New York, NY – March 19, 2024 – Following a challenge brought by the National Advertising Division, Mobile Fox Limited discontinued certain advertising claims promoting its Solitaire Arena mobile app game.